Quest Diagnostics Inc

DGXNYSE · USD
246.45USD0.00 (-0.41%)
779

Quest Diagnostics Inc (DGX) Expected Move

DGX expected move through Oct 16, 2026 is 5.8%, with 25 days to expiration. The implied range is $232.10 to $260.80, based on the previous trading day's options prices.

Read more

Tracking the DGX expected move helps you see how far Quest Diagnostics Inc's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Quest Diagnostics Inc's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the DGX expected move for this week's options, in real time.

The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For DGX, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The DGX expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Quest Diagnostics Inc is unlikely to go.

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals.

The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the DGX expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Quest Diagnostics Inc expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about DGX.

DGX Price

EARN
EM

Drag chart to pan. Drag axes to zoom.

ExpirationDTEExpected move (USD)Expected move (%)Upper priceLower price
Oct 16, 202625$14.355.8%$260.80$232.10
Nov 20, 202660$23.689.6%$270.13$222.77
Feb 19, 2027151$33.3313.5%$279.78$213.13
May 21, 2027242$41.9017.0%$288.35$204.55

As of September 18, 2026

Know What the Market Expects From DGX

Track the DGX expected move across every expiration, filter by IV rank and liquidity, and trade around the range the market is already pricing in.

Start your 14-day free trial